Principal Scientist, mRNA-tLNP Analytical Development

Posted One Month Ago
Be an Early Applicant
Boston, MA, USA
In-Office
Senior level
Biotech
The Role
Lead analytical method development and execution for mRNA and targeted LNP programs, focusing on biophysical and biochemical characterization, antibody-lipid conjugate analytics, CRO oversight, regulatory-compliant method qualification, and authoring analytical sections for INDs and other submissions.
Summary Generated by Built In

Principal Scientist, mRNA-tLNP Analytical Development

About Kernal Biologics, Inc.

Kernal Bio is a venture-backed therapeutics company engineering cells inside the body using AI-designed, selective mRNA and targeted lipid nanoparticle (tLNP) technology. By developing in vivo CAR-T therapies, Kernal Bio is advancing precision treatments for autoimmune diseases and blood cancers.

The company was founded by experts from MIT, Harvard, Merck, and Bristol Myers Squibb. Its leadership team brings a track record that includes three FDA-approved therapies and more than 120 patents. With support from leading investors—including Hummingbird Ventures, Amgen Ventures, Y Combinator, and HBM—Kernal Bio is transforming the future of cell therapy design and delivery.

Job summary

The Principal Scientist, Analytical Development at Kernal Biologics, will report to the Director of Drug Product Development and will lead the design, development, and execution of analytical methods to support the company’s mRNA platform for in vivo CAR-T programs. This role focuses on biophysical characterization and in vitro assay development for early-stage programs, with particular emphasis on antibody-targeted LNPs — including characterization of the antibody–lipid conjugates and the ligand-decorated particles they produce. The ideal candidate will bring deep expertise in analytical sciences, regulatory submissions, and fit-for-purpose method development and validation that support phase-appropriate requirements, along with a demonstrated track record of supporting product development. 

Location: Boston, MA (hub-based; onsite)

Responsibilities

  • Lead the development and execution of bioanalytical methods for early-phase programs
  • Serve as a subject matter expert in mRNA, LNP, and antibody-conjugated (targeted) LNP analytical method development and data interpretation
  • Collaborate cross-functionally to design and implement bioanalytical strategies for pre-clinical development programs
  • Oversee and manage outsourced bioanalytical studies for mRNA and LNP platforms
  • Develop and qualify methods to characterize antibody–lipid bioconjugates and targeted LNPs, including conjugation efficiency, antibody-to-particle ratio and surface ligand density, free/unconjugated antibody, conjugate identity and integrity, and antigen-binding activity
  • Author and develop method protocols and analytical development plans aligned with program goals, regulatory requirements, and compliance standards
  • Provide leadership to ensure GLP and GMP compliance across bioanalytical activities in both nonclinical and clinical studies
  • Author and review bioanalytical sections of INDs and other regulatory submissions

Qualifications

  • PhD (6+ years), MS (8+ years), or BS (12+ years) in Chemistry, Biochemistry, Biology, Pharmaceutical Sciences, or a related field, with relevant industry experience
  • Demonstrated expertise in developing analytical methods to test and characterize mRNA and LNP products, spanning both biophysical and biochemical techniques (particle size measurement, HPLC, LC-MS, CE, ELISA, qPCR, protein analysis, and in vitro potency assays).
  • Strategic understanding of characterization approaches for mRNA, LNPs, biologics, monoclonal antibodies, and related modalities and bioconjugations 
  • Hands-on experience with targeted delivery systems and bioconjugation chemistry, and with the analytics used to characterize them — SEC/HPLC, LC-MS, capillary electrophoresis, ELISA or other binding assays, and orthogonal particle characterization
  • Experience providing technical oversight of CRO/CDMO analytical activities, including ICH-compliant stability programs and GMP testing
  • Experience with cell-based potency assay development, qualification, and troubleshooting is highly desirable
  • Strong knowledge of CMC regulatory expectations and analytical requirements for global regulatory submissions

Benefits

- Competitive 401(k) plan.

- Highly competitive healthcare coverage, including PPO and HMO (with HSA) options.

- Free parking, a monthly subway pass, or a subsidized commuter rail pass.

- Free Bluebikes membership.

- Gym membership support.

- Flexible and health Spending account.

- Paid parental, family caregiver, and medical leave.

- Employer-paid life insurance coverage.

- On-site cafeteria.

- Competitive vacation and sick leave.

Equal Employment Opportunity

Kernal Bio is committed to providing a diverse and inclusive work environment and equal employment opportunities to all employees and qualified applicants. We do not discriminate in employment practices based on race, color, national origin, age, sex, gender, sexual orientation, marital or veteran status, religion, disability, or any other status protected by applicable law. Kernal Bio provides reasonable accommodations to qualified individuals with known disabilities in accordance with applicable law.


Skills Required

  • PhD (6+ years), MS (8+ years), or BS (12+ years) in Chemistry, Biochemistry, Biology, Pharmaceutical Sciences, or related field
  • Expertise in analytical methods for mRNA and LNP products including particle size measurement, SEC/HPLC, LC-MS, CE, ELISA, and qPCR
  • Hands-on experience with targeted delivery systems and bioconjugation chemistry (maleimide/thiol, click, site-specific conjugation)
  • Experience developing and qualifying methods for antibody-lipid bioconjugates and targeted LNPs (conjugation efficiency, antibody-to-particle ratio, surface ligand density, free antibody, identity/integrity, antigen-binding activity)
  • Experience providing technical oversight of CRO/CDMO analytical activities, including ICH-compliant stability programs and GMP testing
  • Knowledge of CMC regulatory expectations and analytical requirements for global regulatory submissions; experience authoring bioanalytical sections of INDs
  • Experience with cell-based potency assay development, qualification, and troubleshooting
  • Ability to lead cross-functional teams and ensure GLP and GMP compliance across bioanalytical activities
Am I A Good Fit?
beta
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Cambridge, MA
17 Employees
Year Founded: 2016

What We Do

Kernal Biologics is a biotechnology company developing mRNA therapies that instruct specific cells to produce their own medicine, targeting diseases such as cancer and autoimmune disorders.

Similar Jobs

Liberty Mutual Insurance Logo Liberty Mutual Insurance

APD - Rideshare Commercial Claims Auto Physical Damage Adjuster

Artificial Intelligence • Fintech • Insurance • Marketing Tech • Software • Analytics
Remote or Hybrid
10 Locations
40000 Employees
46K-84K Annually

Hilton Logo Hilton

FT House Person

Software • Hospitality
In-Office
Boston, MA, USA
121228 Employees

Hilton Logo Hilton

Senior Marketing Manager

Software • Hospitality
In-Office
Boston, MA, USA
121228 Employees

Hilton Logo Hilton

Sales Manager

Software • Hospitality
In-Office
Boston, MA, USA
121228 Employees

Similar Companies Hiring

Formation Bio Thumbnail
Artificial Intelligence • Big Data • Healthtech • Biotech • Pharmaceutical
New York, NY
150 Employees
SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Artificial Intelligence • Healthtech • Machine Learning • Natural Language Processing • Biotech • Pharmaceutical
New York, NY
121990 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account